Discovery on Target

In person

Our team participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

On Tuesday September 25th ZoBio CEO, Gregg Siegal presented the lecture: ‘The Art of Crafting a Mode of Action: Site Selective Hit Discovery”.

During the entire conference the ZoBio team was present at the booth answering the questions about our capabilities.